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SUMMARY

The colon epithelium is a primary point of interaction with the microbiome and is regenerated by a few rapidly
cycling colonic stem cells (CSCs). CSC self-renewal and proliferation are regulated by growth factors and the
presence of bacteria. However, the molecular link connecting the diverse inputs that maintain CSC homeostasis remains largely unknown. We report that CSC proliferation is mediated by redox-dependent activation
of epidermal growth factor receptor (EGFR) signaling via NADPH oxidase 1 (NOX1). NOX1 expression is CSC
specific and is restricted to proliferative CSCs. In the absence of NOX1, CSCs fail to generate ROS and have a
reduced proliferation rate. NOX1 expression is regulated by Toll-like receptor activation in response to the
microbiota and serves to link CSC proliferation with the presence of bacterial components in the crypt.
The TLR-NOX1-EGFR axis is therefore a critical redox signaling node in CSCs facilitating the quiescent-proliferation transition and responds to the microbiome to maintain colon homeostasis.

INTRODUCTION
The integrity of the intestinal epithelium is maintained by continuous cellular regeneration and depends on proliferation of stem
cells at the base of each crypt in the small intestine and colon.
Proliferating colonic stem cells (CSCs) transition to rapidly dividing
transit-amplifying cells before terminally differentiating into one of
several epithelial cell types that make up the majority of the colonic
crypt (van der Flier and Clevers, 2009). However, only a small subpopulation of rapidly cycling cells is responsible for self-renewal
because most CSCs are quiescent (Barker et al., 2007).
Colon homeostasis is regulated by various signals in the stem
niche responsible for the transition between CSC quiescence
and proliferation, as well as the CSC proliferation rate. In turn,
these processes depend on cell-intrinsic factors, positioned
along the crypt, as well as external cues, such as the presence
of luminal microbiota (Carulli et al., 2014; Larsson et al., 2012).
However, the molecular determinants integrating these diverse
inputs and outputs to tune CSC behavior and crypt maintenance
are not fully understood. The WNT, NOTCH, and epidermal
growth factor (EGF) receptor (EGFR) signaling pathways are
essential cell-intrinsic factors responsible for maintaining CSC
stemness and proliferation because chemical or genetic interference of these pathways in the crypt result in differentiation and a
reduction in the size of the stem cell compartment (Barker et al.,
2007; van Es et al., 2005; Wong et al., 2012). Although WNT and

NOTCH are essential for CSC maintenance, EGFR signaling
drives CSC proliferation, and inhibiting this pathway results in
quiescence. Proliferation can be restored when EGFR inhibition
is released, giving rise to the concept of a CSC ‘‘quiescent-proliferation switch’’ (Basak et al., 2017).
The major external stimulus of CSC proliferation is the presence
of microbiota and its metabolites in the intestinal lumen. The microbiome is sensed by the colon via pattern-recognition receptors
(PRRs), including Toll-like receptors (TLRs), to tune CSC proliferation. PRRs regulate the downstream transcription of genes via
nuclear factor kB (NF-kB) (Takeuchi and Akira, 2010). In the
absence of TLR4, or its adaptor molecule Myd88, the intestinal
epithelium fails to initiate the rapid proliferation response needed
to re-populate the epithelium in an induced colitis model (Santaolalla et al., 2013). Conversely, epithelial cell-specific overexpression or constitutive activation of TLR4 results in increasing
numbers of proliferative cells and elongated crypts in the colon
(Fukata et al., 2011). However, a mechanistic link between TLR
signaling and CSC proliferation to coordinate and maintain colon
homeostasis and health is not fully established (Abreu, 2010).
There are numerous reports linking redox biology with maintenance of the intestinal epithelium, primarily through the NADPH
oxidase family (NOX/DUOX) (Pérez et al., 2017). DUOX2 and
NOX1 are the major contributors to the generation of ROS by
the colonic epithelium in the form of O2. and H2O2 (El Hassani
et al., 2005; Suh et al., 1999). Mucosal wound healing is reduced

Cell Reports 35, 108949, April 6, 2021 ª 2021 The Author(s). 1
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

ll
OPEN ACCESS

A

Article
Figure 1. NOX1 expression increases along
the length of the intestine, and its expression
is restricted to stem cells
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in the colon of NOX1 knockout mice because of failure of the
crypts to respond by increasing proliferation, indicating that
NOX1 may be an important driver of CSC proliferation (Alam
et al., 2014). In addition, NOX1-dependent redox signaling enhances intestinal epithelial regeneration in response to symbiotic
bacteria (Alam et al., 2014; Jones et al., 2013). NOX1 loss-offunction mutations that lack the ability to generate superoxide
have been associated with very early-onset inflammatory bowel
diseases, implying an important role for NOX1 in human disease
pathogenesis (Hayes et al., 2015; Lipinski et al., 2019; Schwerd
et al., 2018). Subunits of the NOX1 enzyme complex required for
activation, such as NOXO1, have also been implicated in the
regulation of proliferation in the colon (Moll et al., 2018).
However, the mechanistic details about how redox signaling
directly impacts these diverse biological processes in the very
dynamic intestinal epithelium are far from established. One possibility that is widely proposed is that reactive oxygen species
(ROS) serve as a defensive mechanism keeping the bacteria at
a distance from the colonic epithelium. This extends from the
well-known role of NOX2-derived ROS in phagocytic immune
cells to eliminate opsonized bacteria via generation of a high
concentration of O2. (Pollock et al., 1995). Defensive, cellnonautonomous ROS is important for clearing intestinal pathogens, as shown during virulent Salmonella infections in mice
lacking NOX2 (Cybb), which have an increased susceptibility to
infection (Mastroeni et al., 2000).
However, the ROS produced by NOX in epithelial cells are
generally considered to be too low a level to have a direct bactericidal effect (Botteaux et al., 2009). For example, NOX1 has been
demonstrated to not substantially contribute to pathogen defense
in knockout mice infected with Salmonella typhimurium or Citrobacter rodentium (Chu et al., 2016; Pircalabioru et al., 2016). Physiological levels of ROS can function in a non-defensive role by
altering protein activity via oxidation of redox-sensitive cysteine
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(A) Expression of NOX1 along the gastrointestinal
tract of mice assessed by qPCR. Data are presented as fold change compared with duodenum
(n = 3). Data are represented as mean ± SEM.
(B) Relative mRNA expression of LGR5, NOX1,
MUC2, and FABP1 in undifferentiated spheroids
(stem cells) or differentiated into enterocytes
(L-161-982) or goblet cells (DAPT) (n = 3). Data are
represented as mean ± SD.
(C) FACS isolation of LGR5-EGFP+ and LGR5EGFP distal colon epithelial cells and the relative
mRNA expression of cell-type markers in the two
sorted populations. Data are represented as mean ±
SEM.
(D) In situ hybridization of NOX1 in distal colon tissue.
Scale bars, 30 mm.
**p < 0.01, ***p < 0.001 by one-way ANOVA and Tukey’s posttest.

thiols in proteins such as kinases and phosphates (Held, 2020; Rhee, 2006). ROS produced by NOX1 in the epithelium have been
proposed to regulate colonic homeostasis by acting with both the
host and in bacteria in the intestinal lumen, although the mechanistic details and signaling pathways regulated are largely unknown (Jones and Neish, 2017). Thus, the role of physiological
levels of ROS produced by NOX1 in epithelial cells should be
considered beneficial for maintenance of intestinal homeostasis
and may act cell autonomously.
In the present study, we provide evidence that NOX1 in the
colonic epithelium is specifically expressed by CSCs depending
on proliferation state. Proliferating CSCs express high levels of
active NOX1 compared with quiescent cells. Increased NOX1derived ROS is responsible for redox-dependent activation of
the EGFR signaling pathway, which promotes CSC proliferation.
We also show that induction of NOX1 expression is regulated via
the TLR-NF-kB signaling axis in response to the presence of
microbiota in the colon. NOX1 is therefore an important regulator
of CSC homeostasis and NOX1-dependent redox signaling
mechanism connecting changes in bacterial TLR activation
with EGFR activation to drive CSC proliferation. This regulatory
model explains how NOX1 promotes colon epithelial turnover
and maintains colon health.
RESULTS
NOX1 expression is restricted to CSCs
NOX1 has been shown to be highly expressed along the gastrointestinal tract compared with other tissues, although its celltype-specific expression within the colon remains unresolved
(Suh et al., 1999). Relative mRNA expression analysis of NOX1
in mice tissue shows a gradient in expression along the entire
digestive tract in a proximal-to-distal direction from stomach to
colon (Figure 1A). Within the colon, NOX1 expression gradually
increased through the proximal three-fourths but decreased
slightly in the far distal colon.
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Figure 2. NOX1 is the major source of H2O2
and O2. in colonic stem cells
(A) O2. production over 30 min in wild-type (WT)
and NOX1y/ spheroid cultures treated with the
NOX1 inhibitor ML171 quantified with L-012 (n = 3).
***p < 0.001 by two-way ANOVA with Sidak’s
correction for multiple comparison.
(B) H2O2 production per hour by WT and NOX1y/
stem cultures treated with the NOX1 inhibitor
ML171 quantified with the H2O2-specific probe
Amplex red (n = 3). **p < 0.01 by one-way ANOVA
and Tukey’s posttest. Data are represented as
mean ± SEM.

The colonic epithelium is composed of enterocytes, goblet
cells, enteroendocrine cells, and tuft cells all originating from
the stem cells at the base of the crypt. To identify which cells
in the colonic epithelium express NOX1, we used mouse
spheroid cultures derived from the distal colon that were left undifferentiated or differentiated into absorptive or secretory cells
(Basak et al., 2017; Miyoshi et al., 2017). Terminal differentiation
efficiency was confirmed by probing for lineage-specific markers
of stem cells (leucine-rich repeat-containing G-protein coupled
receptor 5 (LGR5)), enterocytes (fatty acid-binding protein
(FABP1)), and goblet cells (Mucin-2 (MUC2)) (Figure 1B). NOX1
expression was significantly reduced upon differentiation (397fold reduction in enterocytes and 140-fold reduction in the goblet
cell population, respectively), indicating that NOX1 is selectively
expressed in CSCs.
To confirm the specific expression of NOX1 in colon stem
cells in vivo, we used Lgr5-GFP knockin mice (Lgr5-EGFP-iresCreERT2) (Barker et al., 2007). Epithelial cells were isolated
48 h after tamoxifen treatment and sorted by fluorescence-activated cell sorting (FACS) into an EGFP+ stem cell or EGFP population (Figure 1C). Analysis of the EGFP+ and EGFP population
for NOX1 expression, along with the stem cell markers achaetescute homolog 2 (ASCL2) and LGR5, were found to be highly enriched in the EGFP+ cell populations, confirming that NOX1
expression is restricted to CSCs. Lgr5-EGFP-IRES-creERT2
expression is known to be variegated in the intestinal epithelium,
resulting in some EGFP stem cells after recombination. Thus,
the high degree of enrichment of LGR5, ASCL2, and NOX1 in
EGFP+ cells indicates the very specific expression of NOX1 in
CSCs in vivo.
In addition, NOX1 localization was confirmed to be at the
base of the colonic crypt and absent in the underlying tissue
using in situ hybridization (Figure 1D). A negative control for
the NOX1 in situ hybridization probe in NOX1y/ tissue had
no signal, confirming the probe specificity (Figure S1A). In
situ hybridization was also performed on distal ileum tissue
to confirm the observed low NOX1 expression level in the
small intestine (Figure 1A). Only low NOX1 expression was
observed, which was spatially restricted to the base of the
crypt (Figure S1B). NOX1 expression is therefore restricted
to LGR5+ CSCs at the base of the crypt and highly abundant
in the colon.

NOX1 is the major source of ROS in CSCs
NOX1 and DUOX2, another NOX family member, are the major
producers of ROS in the intestinal epithelium (Lambeth, 2004;
Pircalabioru et al., 2016). To determine which NOX family member was the major contributor to ROS production in CSCs, we
first assessed their relative expression. DUOX2 mRNA expression in stem cell-enriched colonic spheroid cultures was found
to be three orders of magnitude lower than NOX1 (Figure S2A).
Upon differentiation, DUOX2 expression was increased in both
the enterocyte and goblet cell populations (Figure S2B). The
limited expression of DUOX2 in CSCs is consistent with previous
findings in which DUOX2 was found to be expressed primarily at
the tip of the crypts (Sommer and Bäckhed, 2015). The spatial
separation of NOX1 and DUOX2, as well as the cell-type-specific
expression, indicates they have distinct roles in the colonic
epithelium.
The role of NOX1 as the exclusive ROS-generating enzyme in
CSCs was further established with the use of spheroid cultures
derived from wild-type and NOX1y/ mice. The catalytic activity
of NOX1 was measured with the luminescent probe L-012 (O2.)
or Amplex red (H2O2). The generation of both forms of ROS was
significantly reduced in the NOX1y/ colonic spheroids and could
be inhibited to baseline by the NOX1 inhibitor ML171 in wild-type
spheroids (Figures 2A and 2B). Notably, these assays were performed in the absence of phorbol-12 myristate 13-acetate (PMA)
that stimulates NOX enzyme activity, indicating that NOX1 in
CSCs has high intrinsic basal activity. NOX activity independent
of stimulation was previously observed in guinea pig primary intestinal cultures and is in contrast with colon cancer lines where
NOX1 activation requires PMA (Kawahara et al., 2004). These results indicate that high levels of active NOX1 are found in CSCs
at the base of the crypt, where it is the predominant source of
basal ROS generation.
NOX1-derived ROS promote CSC proliferation
ROS have been implicated to be an important transducer of proliferative signaling in several epithelial model systems (Dickinson
et al., 2011; Ranjan et al., 2006). To establish if NOX1y/ deletion
affected CSC proliferation, we performed time-course imaging
comparing NOX1y/ with wild-type spheroid cultures. NOX1y/
spheroids showed a significant reduction in growth with no effect
on spheroid formation, indicating that the growth deficit is due to
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Figure 3. NOX1 affects colonic stem cell proliferation
(A) Representative images of WT and NOX1y/
spheroid cultures.
(B and C) Spheroid growth of WT and NOX1y/ cultures treated for 48 h with media containing 1 mM
NAC (B) and measurements of spheroid growth (n = 3,
100 spheroids) (C).
(D) Representative images of proliferative cells (EdU+)
in crypts of WT and NOX1y/ distal and proximal colon
from mice treated with EdU for 2 h.
(E) Quantification of the number of EdU+ cells per
crypt in the proximal (PC) and distal colon (DC) of WT
and NOX1y/ mice (n = 6, 7–12 crypts).
Scale bars, 25 mm. *p < 0.05, ***p < 0.001 by one-way
ANOVA and Tukey’s posttest. Data are represented
as mean ± SEM.

D

E

a decreased proliferative rate (Figure 3A; Video S1). Treatment of
the spheroid cultures with N-acetyl cysteine (NAC), a general
antioxidant, reduced the growth of both wild-type and NOX1y/
spheroids significantly (Figures 3B and 3C). NOX1-derived
ROS are therefore required to maintain basal proliferation in
CSCs.
We next quantified the role of NOX1 on CSC proliferation
in vivo in both the distal and proximal colon by short-term 5-ethynyl-20 -deoxyuridine (EdU) incorporation. We observed a significant reduction in the number of cells in S-phase compared
with NOX1 mutant animals in the distal colon, while no changes
were observed in the proximal colon, which expresses less
NOX1 (Figures 3D and 3E). These results show that NOX1 is
needed for stem cell proliferation in both primary spheroid cultures and in vitro in the distal region of the colon, where it is predominantly expressed.
NOX1 expression and activity in CSCs are a marker for
proliferation state
The majority of the CSCs at the crypt base are found in a quiescent
state, and only a small subset of fast cycling proliferative cells are
responsible for the renewal of the epithelium. The switch between
these two states can be mediated by the growth factors WNT and
EGF, as well as environmental factors, such as the bacterialderived short-chain fatty acid butyrate, an histone deacetylase
(HDAC) inhibitor that is found in high concentrations in the colonic
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lumen (Kaiko et al., 2016; Sato et al., 2011).
The EGFR signaling pathway is essential to
maintain CSCs in a proliferative state,
because inhibition or withdrawal of EGFR ligands leads to CSC quiescence that can be
reactivated to reinstate proliferation (Basak
et al., 2017). To address if NOX1 was differentially expressed in proliferative versus
quiescent CSCs, we treated spheroids with
gefitinib to block EGFR activity and proliferation. We observed a significant reduction in
spheroid growth upon EGFR inhibition in
conditioned media, confirming that the cells
become quiescent (Figure 4A). mRNA
expression of NOX1 was significantly reduced in spheroids
induced into quiescence by either inhibition of EGFR or upon
treatment with butyrate (Figure 4B). Upon removal of butyrate,
CSCs re-enter the cell cycle and continue to proliferate as indicated by the reinstated expression of marker of proliferation Ki67 (MKi67) and cyclin B1 (CCNB1) coinciding with NOX1 expression (Figure 4C). NOX1 expression is therefore tightly regulated by
the proliferation state in CSCs.
Next, we addressed if altered NOX1 mRNA expression in
quiescent versus proliferating spheroids would parallel its enzymatic activity and ROS production. NOX1-derived O2. production was measured with luminol in quiescent spheroid cultures
treated with either gefitinib or butyrate. Both inhibitors resulted
in reduced enzyme activity, comparable with the level observed
in NOX1y/ cultures (Figure 4D).
We next assessed if NOX1 was expressed in proliferating cells
in the distal colon in vivo by co-localizing NOX1 expression by in
situ hybridization with short-term EdU treatment to mark proliferating cells. The colocalization of NOX1 to EdU was similar to the
in situ hybridization pattern of the canonical proliferation marker
MKi67 (Figure 4E). NOX1 expression was restricted to the stem
cell compartment, and an average of 83% of the cells in S-phase
were NOX1-expressing, comparable with the MKi67 expression
profile (Figure 4F). These results indicate that actively cycling
CSCs in vitro and in vivo express high levels of NOX1 and
generate ROS, which is distinct from quiescent CSCs.
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Figure 4. NOX1 activity and expression are restricted to CSCs during proliferation
(A) Surface of WT spheroids before and after treatment for 24 h with the EGFR inhibitor gefitinib (n = 3, 100 spheroids).
(B) qPCR analysis of NOX1 expression in WT spheroid cultures treated for 24 h with the EGFR inhibitor gefitinib or the HDAC inhibitor butyrate (n = 3).
(C) Relative mRNA expression analysis for LGR5, NOX1, CCNB1, and MKi67 in control, butyrate-induced quiescence, and washout spheroids (n = 3).
(D) Superoxide generation in WT and NOX1y/ cultures treated for 24 h with 1 mM gefitinib or 5 mM butyrate over 30 min (n = 3).
(E) Detection of S-phase cells and NOX1 or MKi67 mRNA expression by in situ hybridization in mouse distal colon sections.
(F) Percentage of cells in both S-phase (EdU+) and NOX1 or MKi67 positive (n = 3, 15 crypts).
**p < 0.01, ***p < 0.001 by one-way ANOVA and Tukey’s posttest. Data are represented as mean ± SEM. Scale bars, 30 mm.

NOX1-derived ROS regulate proliferation by
potentiating EGFR activity
The data implicating NOX1-dependent redox signaling in CSC
proliferation led to the question of which proliferation-dependent signaling pathways were activated by NOX1 activity.
Because EGFR activation is essential for CSC proliferation,
we determined whether NOX1 is involved in its activation. In
addition, EGFR activity has been shown to be regulated via
H2O2 by direct sulfenylation of a cysteine in its kinase domain
independent of ligand binding (Heppner et al., 2016; Truong
et al., 2016).
EGFR phosphorylation was reduced in the NOX1y/ spheroids
cultured under serum-free conditions, indicating that NOX1 activity potentiates EGFR activation in the absence of its ligand.
In addition, the antioxidant NAC reduced EGFR activity in wildtype, but not NOX1y/, spheroids, confirming the redox and
NOX1 dependence of EGFR phosphorylation in CSCs (Figure 5A).
To determine if EGFR is redox modified in a NOX1-dependent
manner, we assayed its cysteine sulfenation by treating spheroid
cultures ex vivo with DYn-2 (Yang et al., 2015). Sulfonated EGFR
was detected only in wild-type cells, indicating that EGFR activation is redox regulated by NOX1 in CSCs (Figure 5B).
To further delineate the role of NOX1 in EGFR signaling, we
supplemented spheroid cultures with EGF for 48 h. This restored
the proliferation defect observed in NOX1y/ spheroids to the

level of the control spheroid cultures (Figure 5C). We confirmed
this result by evaluating if the addition of EGF resulted in an
increased number of proliferative cells in S-phase by EdU incorporation. In wild-type cultures, the average percentage of proliferative cells was 22.2% (±3) independent of EGF treatment,
while in NOX1y/ spheroids, the percentage increased significantly from an average of 8.0% to 20.4% upon EGF treatment
(Figure 5D). Because NOX1y/ spheroids can respond to EGF,
this suggests that NOX1 functions in parallel or upstream to
EGFR. However, because EGFR inhibition itself also affects
NOX1 levels (Figure 4), placing NOX1 downstream of EGFR,
we propose that NOX1 and EGFR are regulated by a feedback
loop that is described in the Discussion.
Growth factor stimulation of receptor tyrosine kinases has
been shown to result in a transient increase in intracellular
ROS (Bae et al., 1997; Rhee, 2006). To confirm that EGF treatment of CSCs increased intracellular ROS levels via NOX1, we
quantified ROS production in EGF-stimulated spheroids. Treatment with EGF increased intracellular ROS levels in a NOX1dependent manner, and an overall higher basal level of intracellular ROS was observed in the wild-type cells compared with
NOX1 mutants (Figures 5E and 5F).
Taken together, increased NOX1 activity and ROS formation in
proliferating CSCs redox-modifies and potentiates EGFR
signaling to support basal proliferation.
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Microbial components induce TLR-dependent NOX1
expression and proliferation in CSCs
Because NOX1 was observed to directly affect EGFR signaling,
we next focused on how NOX1 expression was regulated. In
addition to basal proliferation, colonic epithelial turnover is regulated by the presence of microbial components, so we focused
on the impact of the microbiome on NOX1 expression and function (Thursby and Juge, 2017). NOX1 has been shown to be regulated and activated in intestinal epithelial cells in response to microbial components via PRRs, including TLRs, but to date this
has not been functionally linked to the stem cell compartment
(Kawahara et al., 2004; Ogier-Denis et al., 2008).
We observed that spheroid cultures established from the
different regions between the proximal and distal colon upon
passaging (Figure 6A) did not maintain the differential NOX1
expression observed in vivo (Figure 1A). This suggested that an
external stimulus was absent in our ex vivo spheroid culture
model system. Because the in vivo NOX1 expression gradient
coincides with the increase in bacterial load toward the distal colon, we hypothesized that NOX1 expression might be regulated
in response to microbial components (Donaldson et al., 2016).
Spheroids derived from the distal colon were stimulated with
three different microbial-derived TLR ligands: flagellin, lipopolysaccharide (LPS), or lipoteichoic acid. NOX1 expression was
significantly increased in response to all three TLR ligands (Figure 6B). Next, we confirmed if TLR ligands affected proliferation
in a NOX1-dependent manner by treating spheroids for up to
72 h with varying LPS concentrations. Wild-type spheroids
grew significantly larger over time, while in NOX1y/, reduced
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(A) Western blot analysis of the EGFR phosphorylation status in WT and NOX1y/ spheroid cultures
treated with 1 mM NAC. Values indicate the EGFR/
phosphorylated EGFR (pEGFR) ratio changes
compared with WT control.
(B) Sulfenylation status of EGFR in WT and NOX1y/
spheroid cultures was determined after incubation
with DYn-2 for 1 h followed by biotin pull-down and
western blot analysis. Data are represented as
mean ± SEM.
(C) Surface of WT and NOX1y/ spheroids treated
for 48 h with media supplemented with 50 ng/mL
EGF (n = 3, 100 spheroids). Data are represented as
mean ± SEM.
(D) EdU-positive cells determined by flow cytometry
in WT and NOX1y/ spheroid cultures treated
for 48 h with media containing 50 ng/mL EGF (n = 3).
(E) Representative flow cytometry plots of intracellular ROS detection in wild-type and NOX1y/
spheroids stimulated with EGF (50 ng/mL) for 1 h.
(F) Median CellROX fluorescent intensity of control
and EGF-stimulated wild-type and NOX1 mutant
spheroids as determined by flow cytometry (n = 3).
Data are represented as mean ± SD.
**p < 0.001, ***p < 0.0001 by one-way ANOVA and
Tukey’s posttest.

growth was observed (Figures 6C and 6D). This indicates that
NOX1 acts downstream of the TLR pathway to mediate CSC
proliferation. The unexpected reduction in growth in NOX1y/
spheroids upon chronic LPS treatment is potentially due to pleiotropic effects of TLR signaling that are independent of NOX1.
TLR receptors signal by activating the NF-kB pathway primarily via Myd88. To determine if NOX1 is a downstream target of
NF-kB and induced by TLR signaling, we quantified NOX1
mRNA expression upon inhibition of the interleukin-1 receptorassociated kinase 4 (IRAK4), which is an essential effector of
the NF-kB pathway. This was performed in combination with
LPS to stimulate TLR signaling. NOX1 transactivation was inhibited upon IRAK4 inhibition, confirming that NOX1 is downstream of NF-kB in CSCs (Figure 6E). Expression analysis of
additional known NF-kB targets confirmed the efficiency of
IRAK4 inhibition (Figure S3).
In contrast, basal NOX1 expression was independent of
NF-kB signaling. Spheroid cultures derived from Myd88/
mice had a similar level of NOX1 mRNA expression compared
with wild type. No significant increase in NOX1 mRNA expression was observed in Myd88/ spheroids upon LPS treatment
(Figure 6F), similar to IRAK4 inhibition, confirming the TLR
dependence of NOX1 induction. To determine if the regulation
of NOX1-derived ROS production required NF-kB activation,
we determined spheroid O2. generation capacity by luminol in
wild-type, Myd88/, and NOX1y/ spheroids in the presence
or absence of different TLR ligands. No significant difference in
NOX1 activity was observed between Myd88/ and wild-type
spheroids in the absence of TLR stimulation, while upon LPS
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stimulation a significant increase in ROS was observed between
wild-type and Myd88/ (Figure 6G). Together, these indicate
that NOX1 is preferentially regulated via Myd88.
The increase in ROS production by LPS stimulation in
Myd88/ cells implied that TLR4 may act in part via TRIFdependent signaling. We further evaluated this by stimulating
spheroids with the TLR3 ligand polyinosinic-polycytidylic acid
(poly(I:C)), which acts exclusively via TRIF, which did not induce
a ROS response. None of the TLR ligands induced increased
O2. generation in the NOX1y/, confirming NOX1 dependence
(Figure 6G). The functional effect of the lack of an inducible
NOX1 response on CSC proliferation was evaluated in Myd88/
spheroids. In contrast with wild-type spheroids, Myd88/
spheroids did not increase proliferation upon LPS stimulation
(Figure 6H).
Taken together, induction of NOX1 mRNA and ROS production by TLR signaling mediated by Myd88 and NF-kB increases
CSC proliferation.
Microbial depletion and colonization affect NOX1
expression and cell proliferation in vivo
To validate the bacterial dependence of NOX1 regulation in vivo,
we treated mice with a combination of broad-specific antibiotics
to reduce the colonic microbial load (Figure S4A). The mRNA
expression level of NOX1 was significantly reduced in the distal
colon when less bacteria were present, whereas no effect was
observed in the proximal colon (Figure 6I). Next, we determined
the number of proliferative cells (EdU+) by flow cytometry after
antibiotic treatment in the two colon regions, comparing wildtype and NOX1y/ mice. In the distal colon, the number of proliferative cells in the NOX1y/ mice at baseline was reduced significantly as observed earlier based on histology. Antibiotics further
reduced the number of proliferating cells, but there was no
longer a proliferation difference between wild-type and NOX1y/
mice (Figure 6J). These results indicate that NOX1 expression is
regulated by the presence of microbiota in vivo, where it increases CSC proliferation in the distal colon. Conversely,
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NOX1 expression is not affected by antibiotic treatment in the
proximal colon (Figure 6I), which coincides with no NOX1dependent change in CSC proliferation by changes in microbiota
content (Figure 6J).
The induction of NOX1 expression by microbiota in vivo was
further characterized by conventionalizing (Conv-D) germ-free
(GF) mice using microbiota from conventionally raised (ConvR) mice. Microbial colonization is established and maintained
at Conv-R level after 1 week of conventionalization (Figure S4B).
Introduction of bacteria to the intestine of GF mice induced a
significant proliferative response that was maintained over a
4-week time period (Figures 6K and 6M) and coincided with
a significant increase in NOX1 expression (Figure 6L). At
week 4, the increase in NOX1 expression and crypt length
diminished and were comparable with GF and Conv-R mice,
indicating that homeostasis had been largely restored. Basal
NOX1 expression level at steady state in GF, Conv-R, and
Myd88/ mice was also at a comparable level, as expected
(Figure 6L). In contrast, NOX1 expression was not significantly
increased in the proximal colon at any time point during
conventionalization (Figure S4C). In addition, the fluorescent
in situ hybridization signal for NOX1 was stronger and present
in more cells at the crypt base in the distal colon upon conventionalization (Figure 6N).
These data describe a mechanism by which the commensal
microbiota regulate epithelial turnover via TLR-dependent induction of NOX1 expression in CSCs that can be adapted in
response to increased or reduced microbial content.
DISCUSSION
The molecular determinants of CSC homeostasis are poorly understood, especially how CSCs sense external changes in the
microbiome and stimulate subsequent proliferation to maintain
the integrity of the intestinal epithelium. In addition, although
the functional benefit of NOX1-generated H2O2 in maintaining
homeostasis, self-renewal, and differentiation is established

Figure 6. Microbial components induce TLR-dependent NOX1 expression and proliferation in colonic stem cells
(A) mRNA expression analysis for NOX1 expression in spheroid cultures after three passages established from four different segments between the proximal and
distal colon (n = 2).
(B) Expression analysis for NOX1 in WT spheroids derived from the distal colon treated for 4 h with flagellin, LPS, or lipoteichoic acid (LTA) (n = 3).
(C) Representative whole-well stitched images of WT and NOX1y/ distal colon spheroids treated with 1 or 10 mg/mL LPS for 72 h (n = 3, 100 spheroids).
(D) Surface of WT and NOX1y/ distal colon spheroids treated with 1 or 10 mg/mL LPS for 72 h (n = 3, 100 spheroids).
(E) Expression analysis for NOX1 in WT spheroids pretreated for 30 min or untreated with the IRAK4 inhibitor (PF06650833) and stimulated for 4 h with LPS (n = 3).
(F) mRNA analysis for NOX1 mRNA expression in WT and Myd88/ cultures in the presence of LPS for 4 h (n = 3).
(G) Superoxide generation as determined by L012 assay in WT, Myd88/, and NOX1y/ colonic spheroids cultures overnight stimulated with the TLR ligands LPS
or poly(I:C) (2.5 mg/mL) (n = 4).
(H) Spheroid surface of WT and Myd88/ colonic-treated cultures with 1 or 10 mg/mL LPS for 72 h (n = 4).
(I) NOX1 expression in proximal and distal colon tissue in control and 1-week antibiotics-treated mice (n = 6).
(J) Quantification of the number of proliferative cells (EdU+) in the PC and DC of WT and NOX1y/ mice after 1 week of broad-spectrum antibiotics treatment, as
determined by flow cytometry analysis (n = 3–4).
(K) Crypt length as measurement for proliferation determined and measured in 12-week-old germ-free (GF) mice colonized with microbiota (Conv-D) from
conventionally (Conv-R) raised mice (n = 6–7).
(L) Relative NOX1 mRNA expression analysis in distal colon tissue following a 4-week conventionalization period of germ-free mice compared with GF, Conv-R,
and Myd88/ mice (n = 6–7).
(M) Representative images of the different time points and conditions for the GF mice conventionalization experiment. Hematoxylin and eosin (H&E)-stained distal
colon sections. Scale bars, 100 mM.
(N) In situ hybridization of NOX1 in colon tissue during 4-week conventionalization. GF, Conv-R, and Myd88/ mice. Scale bars, 40 mm.
*p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA and Tukey’s posttest. Data are represented as mean ± SEM.
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Figure 7. Proposed working model of NOX1
redox signaling in proliferative CSCs
The expression and ROS generation of NOX1 are
restricted to the proliferating stem cells at the base
of the colonic crypt. Basal NOX1-dependent ROS
can redox-modify EGFR to potentiate its activation,
which can be further enhanced via TLR stimulation
that results in increased NOX1 expression. This
feedback loop supports prolonged proliferation of
colon stem cells by the presence of bacteria in the
colonic lumen even in the absence of EGFR ligands.

(Pérez et al., 2017), the molecular mechanisms by which redox
signaling underlies these diverse biological processes are far
from understood. Our study reports a role for redox regulation
in the colon by directly linking the expression of NOX1 to proliferating stem cells at the base of the crypt compartment, where
its activity enhances proliferation via redox activation of EGFR
signaling in a feedback loop upon bacterial sensing (Figure 7).
The marked switch in NOX1 expression between proliferating
and quiescent CSCs is induced via changes in intestinal bacterial
load via the TLR-NF-kB signaling pathway. Thus, NOX1-derived
ROS serve as a sensor mechanistically linking changes in
the microbiota to CSC proliferation, which maintains colon
homeostasis.
We find that NOX1 is a bona fide marker of proliferating stem
cells, similar to MKi67. Under basal conditions, only a small subset of proliferative cells are responsible for continuous selfrenewal of the epithelium, while the majority of the CSCs are in
a quiescent state acting as a clonogenic reserve (Barker et al.,
2007). We show that NOX1 expression and ROS production
are tightly regulated during the transition into a proliferative state
in concordance with, and to the same extent as, canonical cellcycle genes such as Cyclin-B1. The coregulation of NOX1 and
cell-cycle genes is highly specific to stem cells in the colon
(Kaiko et al., 2016). The transient and short window of proliferation means that NOX1-derived ROS can be produced briefly at
high levels to potentiate the quiescent-proliferation transition
and proliferation rate before being downregulated upon differentiation to minimize oxidative stress.
The molecular mechanism of NOX1 in CSC proliferation and
the quiescent-proliferation switch is via redox activation of the
EGFR pathway. NOX1-derived ROS directly redox-modify and
modulate EGFR activity in our colonic CSC model system in
which wild-type spheroids were capable of maintaining EGFR
activation in the absence of the EGF ligand for an extended
time period compared with NOX1y/ mutants (Jagadeesha
et al., 2012). The addition of antioxidants reduced CSC prolifer-

ative capacity and EGFR phosphorylation,
indicating the redox dependency of EGFR
activation. Antioxidants or NOX inhibitor
treatment results in reduced intracellular
H2O2 generation and signal transduction
upon growth factor stimulation (ten Freyhaus et al., 2006; Sundaresan et al.,
1995). We observed a substantial increase
in NOX1-dependent intracellular ROS
upon EGF stimulation in CSCs, indicating that a similar signal
transduction mechanism responsible for potentiating EGFRdriven proliferation is present in the intestine. These results are
consistent with the fact that physiological levels of H2O2 can activate EGFR independent of ligand binding via the redox modification of a key regulatory cysteine within the EGFR kinase domain
(Heppner et al., 2016; Truong and Carroll, 2012). To date, the
mechanistic importance of ROS in CSC proliferation has been
only established in the context of colorectal cancer, where the
GTPase RAC1 activates NOX1 upon APC loss to drive hyperproliferation (Cheung et al., 2016; Myant et al., 2013). Rescuing the
NOX1-dependent proliferation phenotype via treatment with
exogenous H2O2, which is rapidly metabolized and targets
different cysteines than endogenously produced H2O2 (Behring
et al., 2020; Millonig et al., 2012), is not technically feasible. However, our results are consistent with the other studies demonstrating that H2O2 is the key mediator of NOX1-dependent proliferation (Arnold et al., 2001).
The cell-autonomous role of NOX1-derived ROS may also
have a non-mutually exclusive antimicrobial role whereby ROS
also prevents bacterial invasion into crypt. Antimicrobial activity
has been clearly demonstrated for DUOX2, which, in contrast
with NOX1, is solely expressed at the tip of the crypt in closer
proximity to the luminal microbiota (Sommer and Bäckhed,
2015). The role of NOX1-dependent ROS as both a mediator of
CSC self-renewal and bacterial defense acting in parallel could
be at the base of an improved wound repair in mouse (Kato
et al., 2016; Leoni et al., 2013).
In the intestine, host-microbe interactions signal via TLRs,
which are required to maintain intestinal homeostasis and are
essential for epithelial renewal during wound healing (RakoffNahoum et al., 2004). NOX1 expression and activity in the intestine have been implicated in the response to the abundant
microbiota in the intestinal lumen, but its role and regulation
remain unresolved (Aviello and Knaus, 2018; Jones and
Neish, 2017). We find that there are two roles of NOX1 activity
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in CSCs. First, basal NOX1 expression and activity potentiate
CSC proliferation at steady state. Second, an adaptive
response by stimulation with bacterial components can further
augment NOX1 activity in a TLR-Myd88-dependent manner.
The role of NOX1 in epithelial homeostasis in the colon at steady
state is supported by similar basal NOX1 expression in wildtype, GF, and Myd88/ mice. In addition, basal proliferation
of CSCs in vivo and ex vivo is decreased in the absence of
NOX1.
Complementarily to this intrinsic role of NOX1 in CSCs, we
show that NOX1 expression can also be induced via TLR
signaling in order to adapt to changes in the microbiome. We
observed that both proliferation and NOX1 expression were
significantly reduced specifically in the distal colon of mice
upon antibiotic treatment. The observed reduction in proliferation after antibiotics treatment in the NOX1 mutant indicates
that the microbiota can affect proliferation in the colon through
NOX1-independent routes. In addition, GF mice colonized with
intestinal microbiota provoked an increase in both proliferation
and NOX1 expression over a 4-week time window, but after
this period both returned to baseline. This indicates there is an
adaptive NOX1 response upon bacterial exposure. Given the
functional role of NOX1 in the colon, the inducible NOX1
response serves to protect the host when needed. The importance of TLR-inducible NOX1 expression is also essential during
epithelial wounding or in dextran sulfate-induced colitis models,
where NOX1 plays an important functional role in reconstituting
the damaged epithelium in NOX1 knockout mice (Kato et al.,
2016; Leoni et al., 2013).
CSCs grown ex vivo lose the distinct proximal-to-distal
NOX1 expression gradient observed in vivo, indicating the
importance of host-microbiome interactions on NOX1 expression. Furthermore, microbial stimulation with ligands for TLR2,
TLR4, and TLR5 induced NOX1 expression in spheroid
cultures, providing a direct mechanistic link between the microbiota and NOX1-dependent CSC proliferation. This TLRdependent response is consistent with an increase in bacterial
density along the gut axis that correlates with NOX1 expression. These findings highlight the host’s potential to adapt
CSC proliferation in response to bacterial presence via TLR
signaling.
The presence of niche signals such as WNT and EGF are
essential for intestinal crypt maintenance and provided by interspersed supporting epithelial and mesenchymal cells (Gehart
and Clevers, 2019). Although Paneth cells are absent in the colon, they play a similar supportive role as NOX1 at the crypt
base in the small intestine by secreting growth factors that promote stem cell proliferation and self-renewal in addition to their
role in anti-microbial defense. It is possible that NOX1-generated
ROS have a similar function in the distal colon by compensating
for the reduced growth factor levels in the absence of Paneth
cells.
NOX1 plays a critical role in colonic crypt homeostasis, acting
as a key driver of redox signaling responsible for CSC proliferation and maintenance of the epithelial barrier in response to the
microbiota. Our findings demonstrate that NOX1 is a specific
marker for proliferative stem cells in the colonic crypt capable
of potentiating proliferation by inducible ROS generation.
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NOX1-derived ROS act cell intrinsically in proliferating CSCs to
potentiate EGFR signaling. This signaling axis can be directly
induced by bacterial components, establishing a mechanistic
link between the TLR and EGFR pathways that dynamically increases CSC proliferation in response to changes in the microbiota that enables restoration of homeostasis. Our findings
also provide a plausible, cell-autonomous explanation for the
development of very early onset of inflammatory bowel disease
in patients with NOX1 mutations whereby imbalanced CSC
adaptation in response to the microbiota ultimately triggers a
prolonged immune response.
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Sommer, F., and Bäckhed, F. (2015). The gut microbiota engages different
signaling pathways to induce Duox2 expression in the ileum and colon epithelium. Mucosal Immunol. 8, 372–379.
Suh, Y.A., Arnold, R.S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A.B.,
Griendling, K.K., and Lambeth, J.D. (1999). Cell transformation by the superoxide-generating oxidase Mox1. Nature 401, 79–82.
Sundaresan, M., Yu, Z.-X., Ferrans, V.J., Irani, K., and Finkel, T. (1995).
Requirement for generation of H2O2 for platelet-derived growth factor signal
transduction. Science 270, 296–299.

Ogier-Denis, E., Mkaddem, S.B., and Vandewalle, A. (2008). NOX enzymes
and Toll-like receptor signaling. Semin. Immunopathol. 30, 291–300.

Takeuchi, O., and Akira, S. (2010). Pattern recognition receptors and inflammation. Cell 140, 805–820.
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Held (jheld@wustl.edu).
Materials availability
This study did not generate new unique reagents.
Data and code availability
This study did not generate any unique datasets or code.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
The NOX1/, Lgr5-EGFP-IRES-creERT2, and C57BL/6 mice were obtained from Jackson Laboratories (Bar Harbor, ME, USA) and
all experiments were approved by the Washington University in St Louis institutional animal care and use committee. Myd88/ and
germ-free mice experiments were performed at the University of Gothenburg according to Gothenburg laboratory animal ethics committee guidelines. Mice were housed in a specific pathogen free facility with access to chow and water ad libitum. Animals were used
for experiments in the age range between 8 and 12 weeks, and all were littermate control males. Males were selected as the NOX1
gene is X-linked only allowing male littermate breeding.
Primary cell culture
Mouse spheroid cultures were established and cultured as described previously (Miyoshi and Stappenbeck, 2013).
Briefly crypts were isolated from either the proximal or distal colon of eight week old male mice after collagenase digestion
(Millipore) for 45 minutes. After removal of the intestinal tissue crypts were pelleted by centrifugation and embedded in Matrigel
(Corning) in 24 or 48-well plates. The cultures were passaged three times before used for experiments. Stem cell media was
composed of 50% conditioned media in DMEM/F12 (GIBCO) supplemented with GlutaMAX (GIBCO), 100U Penicillin-Streptomycin (GIBCO), 10mM Y27632 (Cayman) with a final FBS concentration of 10%. Conditioned media was prepared from
L-WRN cells (gift from T. Stappenbeck, ATCC, CRL-3276) engineered to secrete Wnt3a, R-spondin and noggin, filtered and
frozen until use.
METHOD DETAILS
Mice treatments
Mice received a combination of vancomycin, neomycin, ampicillin and metronidazole (Sigma) with the addition of 1% glucose for
one-week ad libitum. Proliferation was assessed 2 hr after inter peritoneum injection with 5-Ethynyl-20 -deoxyuridine (Cayman). Cre
recombineering in the Lgr5-EGFP-IRES-creERT2 mice was achieved after a single inter peritoneum injection with 200 mL tamoxifen (10mg/mL) (Sigma). Conventionalized (Conv-D) mice were generated by colonizing germ-free (GF) C57BL/6 mice with caecal/
faecal microbiota from conventionally raised (Conv-R) C57BL/6 donors. For each experiment, caecal and colonic content was harvested from three ConvR donors under aseptic conditions. Caecal/faecal content was pooled in 10 mL PBS supplemented with
0.1% (w/v) cysteine (Sigma) and homogenized using a T10 ULTRA-TURRAX rotor stator homogenizer (IKA). Freshly prepared homogenate (200 ml) was immediately administered to GF mice via gavage, and the resulting Conv-D mice were subsequently
housed under conventional conditions for the duration of the experiment. Female donor and recipient mice were used for all
conventionalization experiments.
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Primary intestinal epithelial cell treatment
For differentiation assays spheroids were trypsinzed with TrypLE Express (GIBCO) for 1 minute, re-embedded into matrigel (Corning)
and cultured for 24 hr in DMEM/F12, 10mM Y27632, 5 ng/mL EGF with either 5 mM DAPT for goblet cell cultures or 10 mM L-161,982
for enterocyte cultures. Spheroid growth was assessed over 48 to 72 hour time windows obtaining four bright field images at 10x
per well at 1 hr. intervals using a Incucyte ZOOM (Essen BioSciences) microscope, or for full well endpoint stitched images were
obtained for long-term treatment with LPS (Sigma), EGF (R&D systems) or n-acetyl cysteine (Sigma) using a BioTek Cytation5
automated microscope. Data analysis was performed in Fiji for 100 spheroids per condition and represented as sphere surface
in mm2.
mRNA isolation and real-time quantitative PCR
Spheroids were treated for 4 hr before RNA extraction with 1mM ultrapure lipopolysaccharide (InvivoGen), 1 mM lipoteichoic acid
(Sigma) or 0.1 mM flagellin (Sigma) with or without pretreatment with 10 mM PF06650833 (Sigma). Quiescence conditions were
induced by 18 or 36 hr treatment with 1 mM butyrate (Sigma) or 5 mM Gefitinib (Cayman). Snap frozen tissue or spheroids in matrigel
were recovered and homogenized in RLT buffer (QIAGEN). Tissue samples were homogenized with the use of an Ultra Turbax homogenizer T10 (IKA). RNA was extracted using the RNAeasy micro kit (QIAGEN) and converted to cDNA using random hexamers
(High-capacity cDNA kit, Applied biosystems). qPCR analysis were performed using PowerUp SYBR green (Applied Biosystems)
and analyzed on a CFX96 (Bio-Rad) thermocycler and relative abundance changes were calculated using the delta-delta-ct method
by normalization to GAPDH and ACTB expression.
Gel electrophoresis and immunoblot analysis
Spheroids were cultured under serum free conditions in DMEM/F12 with or without 1mM n-acetylcysteine (NAC) for 6 hr and recovered from matrigel using Cell Recovery Solution (Corning) with the addition of phosphatase inhibitor cocktail 2, 3 and 10mM sodium
fluoride (Sigma-Aldrich). Matrigel droplets were incubated for 30 minutes on an end-over-end mixer at 4 C, followed by centrifugation
at 750 x g for 5 minutes. Pelleted spheres were washed once with PBS, lysed in RIPA buffer and the protein concentration was determined by BCA (Invitrogen). Lysates were resolved by electrophoresis on 4%–12% gradient NuPAGE Bis-Tris gels (Invitrogen). Proteins were transferred to nitro cellulose by electroblotting (TransBlot Turbo, BioRad). Blots were blocked with 5% BSA in TBST and
probed with the following primary antibodies for 1 hr anti EGFR (2232, Cell Signaling) or phosphoylated EGFR Tyr-1068 (3777, Cell
Signaling) and detected with HRP conjugated goat anti-rabbit antibody. Blots were imaged by chemiluminescence after treatment
with ECL substrate (BioRad).
Flow cytometry analysis and cell sorting
For FACS analysis epithelial cells from Lgr5-EGFP-IRES-creERT2 mice were isolated from the last 3 cm of the distal colon 48 hr after
tamoxifen treatment. Tissue was opened longitudinal washed three time in PBS then cut into smaller pieces and transferred to cold
HBBS (Ca2+ and Mg2+ free) with 5 mM EDTA and incubated for 75 min on an end-over-end mixer at 4 C. Crypts were pelleted by
centrifugation after vigorously shaking and removal of the tissue. Single cell suspensions were achieved by digestion with TrypLE
(GIBCO) for 30 min in HBBS with 10mg/mL DNase (Roche) at 37 C. The isolated cells from three mice were pooled and sorted
into two populations (EGFP+ and EGFP-) by FACS (Sony SY3200) collected in RLT lysis buffer (QIAGEN) and directly processed
for mRNA extraction as described earlier. To quantify cells in S-phase spheroid cultures were incubated for 2 hr with 10 mM 5-Ethynyl-20 -deoxyuridine (EdU) after which cells were recovered from the matrigel with 5 mM EDTA and digested into single cells using
TrypLE for 45 minutes at 37 C. Cells were fixed in 4% PFA for 15 minutes washed in with 2% BSA in PBS and sulfo-Cy5 azide (Lumiprobe) was conjugated using click-it chemistry. For the click reaction cell pellets were incubated for 30 minutes in 50 mL 2 mM azidesulfo-Cy5, 2 mM CuSO4, 100 mM ascorbic acid in PBS followed by two 15 min. washes in 2% BSA in PBS. The above procedure was
also followed to determine in vivo EdU incorporation, isolating single cell using EDTA and TrypLE as described. Flow cytometry analysis were performed on a FACScan instrument (Becton Dickinson) and data were analyzed using FlowJo v10 (FlowJo LLC). Intracellular ROS was assayed after incubation for 2 hr with 5 mM CellROX green (Molecular probes). Single cell suspensions were generated
as described above with the addition of 2 mM NAC during the TrypLE digestion. Cells were kept on ice in the dark and directly
analyzed as described.
Detection of sulfenylated proteins
To label sulfenylated protein cysteines spheroid cultures were incubated with 2 mM DYn2 [4-(pent-4-yn-1-yl)cyclohexane-1,3-dione]
(Cayman) for 1 hr. Spheroids were recovered and cell lysis was performed as described above in the presence of 5 mM NAC. Labeled
proteins were biotinylated via click-chemistry with 100mM Biotin-Picolyl-Azide (Click Chemistry Tools) in a reaction with the following
components 500mM THPTA [tris-hydroxypropyltriazolylmethylamine] (Click Chemistry Tools), 100mM CuSO4 and 5mM ascorbate,
incubated for 30 min. Excess reagents were removed by filtration using molecular weight cutoff filters (Pall). Biotin labeled protein
were enriched using prewashed streptavidin agarose in spin columns (Pierce) for 1 hr end-over-end mixing, washed twice for
30 minutes with 0.5% SDS followed by centrifugation. Eluted proteins were resolved by electrophoresis, transferred to nitro cellulose
and EGFR was detected by as described earlier.
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Hydrogen peroxide and superoxide detection
Superoxide detection was performed using L-012 in spheroid cultures in the presence of 2.5 mg/mL LPS, 2.5 mg/mL Poly(I:C) HMW
(Invivogen), 20 mM ML171 (Tocris), 1 mM butyrate (Sigma) or 5 mM Gefitinib (Cayman). Cells in matrigel were recovered in prewarmed
37 C Krebb-ringer bicarbonate buffer containing 100 mM L-012 (FUJIFILM, Wako) and transferred to white 96-well plate. Luminescence was measured over a 30 minutes time window at 37 C using an Infinite m200 (Tecan) or CLARIOstar (BMG Labtech) plate
reader. Spheroids were isolated from the matrigel using recovery solution as described before and BCA was used to quantify the
protein concentration used to normalize the assay results. H2O2 generation was measured using the Amplex red assay (Thermo
Fisher). 100mL of 0.2U/mL HRP, 20mM Amplex red in preheated 37 C Krebs-ringer bicarbonate buffer was added to each condition
and incubated for 1 hr. at 37 C. The reaction was quenched and spheroids were disrupted by adding 20 mL 5 mM EDTA and the
supernatant was transferred to a 96 well plate. In parallel a standard H2O2 curve was made prepared to determine the absolute
nmol concentration in the samples. Analyzes were performed on using an Infinite m200 plate reader (Tecan) at excitation 530 nm
and emission 600 nm.
Imaging
NOX1 in situ hybridization combined with antibody staining and EdU detection was performed on distal colon tissue collected from
mice 2 hr after receiving an intraperitoneal injection with 100 mL 20 mM EdU. Dissected tissue was fixed for 16 hr in 4% formaldehyde,
paraffin embedded, dewaxed, pretreatment, antigen retrieval and single molecule in situ hybridization of NOX1 (probe: 464651) or
Mki67 (416771) was performed according to manufacturer’s instructions RNAscope fluorescent reagent kit v2 (ACD, Bio-Techne)
visualized with Opal-570 (Perkin-Elmer). Detection of EdU positive cells was achieved by incubating the sections for 30 minutes
with 4 mM azide-picolyl-A488 (Jena Bioscience), 2 mM CuSO4, 100 mM ascorbic acid in PBS followed by two 15 minutes washed
in PBS. For immunohistochemistry sections were blocked with 1%BSA in PBS and incubated overnight with rabbit Epcam
(1:200, Abcam, ab71916) followed by the secondary Alexa647 goat anti-rabbit antibody (Invitrogen). Nuclei were counterstained
with Hoechst 33528 (1mg/ml) and images were obtained by confocal microscope (Zeiss LSM 700). Imaging of S-phase cells in
wild-type and NOX1y/- mice was done on proximal and distal colon tissue fixed in 4% PFA for 1 hr and embedded in OCT (Fisher)
for cryosectioning. EdU incorporation was detected by click conjugation of azide-sulfo-Cy5 (Lumiprobe) as above and images
were obtained by fluorescent microscopy (Olympus IX70). Images were analyzed in Imaris (Bitplane) or Fiji and statistical analysis
were performed in Prism v8 (Graphpad).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using Prism v7 (GraphPad). All data is presented as mean ± standard error or the mean (SEM).
Unpaired two-tailed t tests or one-way ANOVA with Tukey’s post test for correction of multiple comparisons was performed between
groups. A cut off at p < 0.05 was used for statistical significance. Details regarding the statistical test used in the respective experiments are indicated in the figure legends together with populations size.
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Supplemental figure legends

Figure S1: NOX1 in situ hybridization probe specificity and the expression in the distal ileum (Related to
figure 1). (a) In-situ hybridization for NOX1 in NOX1y/- colon tissue combined with antibody staining for
EpCAM. (b) In-situ hybridization for NOX1 in the distal ileum combined with antibody staining against
EpCAM. Scale bars 30 µm.

Figure S2: Expression levels of NOX1 and DUOX2 in spheroid cultures (Related to figure 1). (a) Copy
numbers of NOX1 and DUOX2 mRNA in relationship to GAPDH determined by qPCR in undifferentiated
colonic stem cells spheroid cultures (n=3). (b) Relative mRNA expression of DUOX2 in undifferentiated
spheroids (stem cells) or into enterocytes (L-161-982) or goblet cells (DAPT) (n=3). *P <0.05 by one-way
ANOVA and Tukey’s post test. Data are represented as mean  SEM.

Figure S3: mRNA Expression of known downstream targets of the NF-kB pathway upon LPS stimulation
(Related to figure 6). Expression analysis for DUOX2 and NOS2 in WT spheroids pretreated and non-treated
with the IRAK4 inhibitor (PF06650833) and stimulated for 4 hr with LPS (n=3). ***P <0.001 by one-way
ANOVA and Tukey’s post test. Data are represented as mean  SEM.

Figure S4: Fecal microbial 16S quantification after antibiotics treatment and germ-free mice colonization,
and the NOX1 expression response in the proximal colon upon bacterial colonization (Related to figure
6). (a) 16S rRNA copy number quantification in fecal content from control and one-week broad-spectrum
antibiotics (ABX) treated wild-type (WT) mice (n=6). Data are represented as mean  SD. (b) Fecal 16S rRNA
quantification during four-weeks of microbial conventionalization (Conv-D) and in conventionally (Conv-R)
raised mice (n=6). Data are represented as mean  SEM. (c) Analysis of relative NOX1 mRNA expression in
proximal colon tissue during four-week conventionalization period, germ free (GF), and Conv-R mice
normalized towards distal colon GF expression (Fig. 6l) (n=3). Data are represented as mean  SEM.

Supplementary video 1 (related to figure 2): Representative time course of wild type and NOX1y/- spheroids
over 72 hours.

